Moclobemide and selegeline in the treatment of depression in Parkinson's disease

Lignende værker

• Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Stopping selegeline may lead to problems for patients.
  af: Anderson, K. E., et al.
  Udgivet: (1996)
• Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Selegeline is effective and safe in early stages.
  af: MacMahon, D. G., et al.
  Udgivet: (1996)
• Moclobemide versus fluoxetine in the treatment of major depressive disorder in adults.
  af: Lapierre, Y D, et al.
  Udgivet: (1997)
• Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Selegeline may be toxic in presence of increased dopamine concentrations.
  af: Yu, P. H., et al.
  Udgivet: (1996)
• Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Parkinson's disease is rarely a primary cause of death.
  af: Silva, M. T., et al.
  Udgivet: (1996)